Kronox Lab Sciences declares ₹0.50 per share final dividend for FY26
- Final dividend of ₹0.50 per equity share approved for FY26
- Jogindersingh Jaswal reappointed as director by rotation
- Audited financial statements for FY26 adopted by shareholders
- Cost auditor remuneration for FY27 ratified

*this image is generated using AI for illustrative purposes only.
Kronox Lab Sciences shareholders approved a final dividend of ₹0.50 per equity share for FY26 during the company’s 17th annual general meeting on September 16, 2026.
The meeting, conducted via video conferencing, also saw the reappointment of Jogindersingh Jaswal as director by rotation and the ratification of cost auditor remuneration for FY27.
Key Resolutions Passed
Shareholders approved four ordinary resolutions during the proceedings:
- Adoption of audited financial statements for the fiscal year ended March 31, 2026
- Declaration of a final dividend of ₹0.50 per equity share for FY26
- Reappointment of Jogindersingh Jaswal (DIN: 02385809) as director
- Ratification of remuneration payable to cost auditors for FY27
Management Presence
Jogindersingh Jaswal, chairman and managing director, presided over the meeting. Other directors present included Ketan Ramani, Pritesh Ramani, Kratika Negandhi, Parth Shah, and Satish Kumar.
Key managerial personnel Samir Gadhiya (chief financial officer) and Nikhil Goswami (company secretary) attended via VC. Statutory auditor Mahesh Udhwani, internal auditor Jaimin Modi, and secretarial auditor Devesh Pathak were also present.
Voting Process
The company secretary confirmed that quorum was present through VC/OAVM facilities provided by Kfin Technologies Limited. Members who had not voted electronically before the meeting were given 15 minutes after its conclusion to cast their votes. Results will be disseminated to stock exchanges and posted on the company website by September 18, 2026.
Historical Stock Returns for Kronox Lab Sciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.69% | -1.97% | +13.95% | +50.97% | -2.39% | +7.66% |
How does the ₹0.50 dividend payout compare to Kronox Lab Sciences' historical dividend yield and peer averages in the clinical research sector?
What strategic initiatives or capital allocation plans has management outlined for FY27 following the ratification of cost auditor remuneration?
Could the reappointment of Jogindersingh Jaswal signal any upcoming shifts in corporate governance or leadership succession planning?


































